{"entity":{"type":"insider","cik":"0001496201","url":"/insider/0001496201","json_url":"/insider/0001496201.json","name":"SPHERA FUNDS MANAGEMENT LTD.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":84,"n_filings":15,"first":"2010-07-29","last":"2021-05-04","span_basis":"filed_date"},"name_variants":[{"name":"SPHERA FUNDS MANAGEMENT LTD.","source":"filing","n_filings":15,"first_seen":"2010-07-29","last_seen":"2021-05-04"}],"transactions":[{"id":4858590,"accession":"0001178913-21-001591","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001178913-21-001591","line_url":"/filing/0001178913-21-001591#line-2","is_derivative":false,"issuer_cik":"0001496201","issuer_name":"Werewolf Therapeutics, Inc.","issuer_ticker":"HOWL","issuer_name_source":null,"issuer_url":"/issuer/0001496201","owner_cik":null,"owner_name":"Sphera Global Healthcare Management LP; SPHERA FUNDS MANAGEMENT LTD.; Sphera Global Healthcare GP Ltd.","owner_display_name":"Sphera Global Healthcare Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":475000.0,"shares_display":"475,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":7600000.0,"total_display":"7,600,000.00","total_whole":"7,600,000","shares_owned_after":787997.0,"shares_owned_after_display":"787,997","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-04","filed_date":"2021-05-04","scope":"insider"},{"id":9013931,"accession":"0001178913-11-002266","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001178913-11-002266","line_url":"/filing/0001178913-11-002266#line-2","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"BREEN DORON; MOR ISRAEL; SENATOR RON; SPHERA FUNDS MANAGEMENT LTD.","owner_display_name":"BREEN DORON","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82109.0,"shares_display":"82,109","price_per_share":2.0043,"price_display":"2.00","price_state":"stated","total_value":164571.0687,"total_display":"164,571.07","total_whole":"164,571","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-08-10","filed_date":"2011-08-11","scope":"insider"},{"id":9013930,"accession":"0001178913-11-002266","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-11-002266","line_url":"/filing/0001178913-11-002266#line-1","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"BREEN DORON; MOR ISRAEL; SENATOR RON; SPHERA FUNDS MANAGEMENT LTD.","owner_display_name":"BREEN DORON","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":81359.0,"shares_display":"81,359","price_per_share":2.1531,"price_display":"2.15","price_state":"stated","total_value":175174.0629,"total_display":"175,174.06","total_whole":"175,174","shares_owned_after":82109.0,"shares_owned_after_display":"82,109","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-08-09","filed_date":"2011-08-11","scope":"insider"},{"id":9013929,"accession":"0001178913-11-001808","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001178913-11-001808","line_url":"/filing/0001178913-11-001808#line-2","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; SENATOR RON; MOR ISRAEL; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1079.0,"shares_display":"1,079","price_per_share":2.1044,"price_display":"2.10","price_state":"stated","total_value":2270.6476,"total_display":"2,270.65","total_whole":"2,271","shares_owned_after":163468.0,"shares_owned_after_display":"163,468","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-06-27","filed_date":"2011-06-28","scope":"insider"},{"id":9013928,"accession":"0001178913-11-001808","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-11-001808","line_url":"/filing/0001178913-11-001808#line-1","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; SENATOR RON; MOR ISRAEL; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7499.0,"shares_display":"7,499","price_per_share":2.1007,"price_display":"2.10","price_state":"stated","total_value":15753.1493,"total_display":"15,753.15","total_whole":"15,753","shares_owned_after":164547.0,"shares_owned_after_display":"164,547","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-06-24","filed_date":"2011-06-28","scope":"insider"},{"id":9043027,"accession":"0001178913-11-001798","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-11-001798","line_url":"/filing/0001178913-11-001798#line-1","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; BREEN DORON; SENATOR RON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":2.0907,"price_display":"2.09","price_state":"stated","total_value":104535.0,"total_display":"104,535.00","total_whole":"104,535","shares_owned_after":172046.0,"shares_owned_after_display":"172,046","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-06-23","filed_date":"2011-06-27","scope":"insider"},{"id":9238299,"accession":"0001178913-11-001791","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001178913-11-001791","line_url":"/filing/0001178913-11-001791","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"BREEN DORON; MOR ISRAEL; SENATOR RON; SPHERA FUNDS MANAGEMENT LTD.","owner_display_name":"BREEN DORON","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":399002.0,"shares_display":"399,002","price_per_share":3.141030613380384,"price_display":"3.14","price_state":"stated","total_value":1253277.4968,"total_display":"1,253,277.50","total_whole":"1,253,277","shares_owned_after":129437.0,"shares_owned_after_display":"129,437","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-06-16","filed_date":"2011-06-23","scope":"insider","n_lines":3},{"id":8860843,"accession":"0001178913-11-001765","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001178913-11-001765","line_url":"/filing/0001178913-11-001765","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"MOR ISRAEL; SENATOR RON; BREEN DORON; SPHERA FUNDS MANAGEMENT LTD.","owner_display_name":"MOR ISRAEL","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":399002.0,"shares_display":"399,002","price_per_share":3.141030613380384,"price_display":"3.14","price_state":"stated","total_value":1253277.4968,"total_display":"1,253,277.50","total_whole":"1,253,277","shares_owned_after":222046.0,"shares_owned_after_display":"222,046","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-06-16","filed_date":"2011-06-20","scope":"insider","n_lines":3},{"id":8876024,"accession":"0001178913-11-001665","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001178913-11-001665","line_url":"/filing/0001178913-11-001665#line-3","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; BREEN DORON; SENATOR RON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":2.22,"price_display":"2.22","price_state":"stated","total_value":7326.0,"total_display":"7,326.00","total_whole":"7,326","shares_owned_after":209629.0,"shares_owned_after_display":"209,629","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-06-03","filed_date":"2011-06-06","scope":"insider"},{"id":8876022,"accession":"0001178913-11-001665","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001178913-11-001665","line_url":"/filing/0001178913-11-001665","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; BREEN DORON; SENATOR RON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17807.0,"shares_display":"17,807","price_per_share":2.364,"price_display":"2.36","price_state":"stated","total_value":42095.748,"total_display":"42,095.75","total_whole":"42,096","shares_owned_after":212929.0,"shares_owned_after_display":"212,929","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-06-02","filed_date":"2011-06-06","scope":"insider","n_lines":2},{"id":9185274,"accession":"0001178913-11-001639","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001178913-11-001639","line_url":"/filing/0001178913-11-001639","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; SENATOR RON; MOR ISRAEL; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":2.4567,"price_display":"2.46","price_state":"stated","total_value":27023.7,"total_display":"27,023.70","total_whole":"27,024","shares_owned_after":227354.0,"shares_owned_after_display":"227,354","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-06-01","filed_date":"2011-06-02","scope":"insider","n_lines":2},{"id":8963455,"accession":"0001178913-11-000930","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001178913-11-000930","line_url":"/filing/0001178913-11-000930","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; BREEN DORON; SENATOR RON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12316.0,"shares_display":"12,316","price_per_share":4.0709,"price_display":"4.07","price_state":"stated","total_value":50137.2044,"total_display":"50,137.20","total_whole":"50,137","shares_owned_after":236264.0,"shares_owned_after_display":"236,264","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-28","filed_date":"2011-03-30","scope":"insider","n_lines":2},{"id":9157762,"accession":"0001178913-11-000895","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001178913-11-000895","line_url":"/filing/0001178913-11-000895","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; BREEN DORON; SENATOR RON; MOR ISRAEL","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":152600.0,"shares_display":"152,600","price_per_share":4.033750196592399,"price_display":"4.03","price_state":"stated","total_value":615550.28,"total_display":"615,550.28","total_whole":"615,550","shares_owned_after":522046.0,"shares_owned_after_display":"522,046","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-24","filed_date":"2011-03-28","scope":"insider","n_lines":2},{"id":8922654,"accession":"0001178913-11-000877","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001178913-11-000877","line_url":"/filing/0001178913-11-000877","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SENATOR RON; BREEN DORON; MOR ISRAEL; SPHERA FUNDS MANAGEMENT LTD.","owner_display_name":"SENATOR RON","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33800.0,"shares_display":"33,800","price_per_share":4.006934319526628,"price_display":"4.01","price_state":"stated","total_value":135434.38,"total_display":"135,434.38","total_whole":"135,434","shares_owned_after":246117.0,"shares_owned_after_display":"246,117","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-23","filed_date":"2011-03-25","scope":"insider","n_lines":3},{"id":8963453,"accession":"0001178913-11-000645","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001178913-11-000645","line_url":"/filing/0001178913-11-000645","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"BREEN DORON; SENATOR RON; MOR ISRAEL; SPHERA FUNDS MANAGEMENT LTD.","owner_display_name":"BREEN DORON","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8300.0,"shares_display":"8,300","price_per_share":3.5334,"price_display":"3.53","price_state":"stated","total_value":29327.22,"total_display":"29,327.22","total_whole":"29,327","shares_owned_after":263692.0,"shares_owned_after_display":"263,692","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-01","filed_date":"2011-03-02","scope":"insider","n_lines":2},{"id":8963451,"accession":"0001178913-11-000645","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-11-000645","line_url":"/filing/0001178913-11-000645#line-1","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"BREEN DORON; SENATOR RON; MOR ISRAEL; SPHERA FUNDS MANAGEMENT LTD.","owner_display_name":"BREEN DORON","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5808.0,"shares_display":"5,808","price_per_share":3.8659,"price_display":"3.87","price_state":"stated","total_value":22453.1472,"total_display":"22,453.15","total_whole":"22,453","shares_owned_after":65696.0,"shares_owned_after_display":"65,696","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-28","filed_date":"2011-03-02","scope":"insider"},{"id":7622436,"accession":"0001178913-10-002137","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-10-002137","line_url":"/filing/0001178913-10-002137#line-1","is_derivative":false,"issuer_cik":"0001382911","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001382911","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; SENATOR RON; MOR ISRAEL; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":4.1495,"price_display":"4.15","price_state":"stated","total_value":82990.0,"total_display":"82,990.00","total_whole":"82,990","shares_owned_after":571877.0,"shares_owned_after_display":"571,877","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-07-12","filed_date":"2010-08-16","scope":"insider"},{"id":7334780,"accession":"0001178913-10-001955","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001178913-10-001955","line_url":"/filing/0001178913-10-001955#line-26","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; SENATOR RON; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4100.0,"shares_display":"4,100","price_per_share":6.3896,"price_display":"6.39","price_state":"stated","total_value":26197.36,"total_display":"26,197.36","total_whole":"26,197","shares_owned_after":270498.0,"shares_owned_after_display":"270,498","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-07-01","filed_date":"2010-07-29","scope":"insider"},{"id":7334778,"accession":"0001178913-10-001955","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001178913-10-001955","line_url":"/filing/0001178913-10-001955#line-25","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; SENATOR RON; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10501.0,"shares_display":"10,501","price_per_share":6.6518,"price_display":"6.65","price_state":"stated","total_value":69850.5518,"total_display":"69,850.55","total_whole":"69,851","shares_owned_after":266398.0,"shares_owned_after_display":"266,398","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-06-30","filed_date":"2010-07-29","scope":"insider"},{"id":7334776,"accession":"0001178913-10-001955","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001178913-10-001955","line_url":"/filing/0001178913-10-001955#line-24","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; SENATOR RON; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":7.1643,"price_display":"7.16","price_state":"stated","total_value":50150.1,"total_display":"50,150.10","total_whole":"50,150","shares_owned_after":71504.0,"shares_owned_after_display":"71,504","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-06-28","filed_date":"2010-07-29","scope":"insider"},{"id":7334775,"accession":"0001178913-10-001955","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001178913-10-001955","line_url":"/filing/0001178913-10-001955#line-23","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; SENATOR RON; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5217.0,"shares_display":"5,217","price_per_share":9.9411,"price_display":"9.94","price_state":"stated","total_value":51862.7187,"total_display":"51,862.72","total_whole":"51,863","shares_owned_after":64504.0,"shares_owned_after_display":"64,504","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-05-04","filed_date":"2010-07-29","scope":"insider"},{"id":7334774,"accession":"0001178913-10-001955","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001178913-10-001955","line_url":"/filing/0001178913-10-001955#line-22","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; SENATOR RON; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":9.444,"price_display":"9.44","price_state":"stated","total_value":113328.0,"total_display":"113,328.00","total_whole":"113,328","shares_owned_after":255897.0,"shares_owned_after_display":"255,897","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-03-31","filed_date":"2010-07-29","scope":"insider"},{"id":7334773,"accession":"0001178913-10-001955","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001178913-10-001955","line_url":"/filing/0001178913-10-001955#line-21","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; SENATOR RON; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":9.5103,"price_display":"9.51","price_state":"stated","total_value":76082.4,"total_display":"76,082.40","total_whole":"76,082","shares_owned_after":243897.0,"shares_owned_after_display":"243,897","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-03-29","filed_date":"2010-07-29","scope":"insider"},{"id":7334771,"accession":"0001178913-10-001955","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001178913-10-001955","line_url":"/filing/0001178913-10-001955","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; SENATOR RON; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43700.0,"shares_display":"43,700","price_per_share":7.273723340961098,"price_display":"7.27","price_state":"stated","total_value":317861.71,"total_display":"317,861.71","total_whole":"317,862","shares_owned_after":686746.0,"shares_owned_after_display":"686,746","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-02-10","filed_date":"2010-07-29","scope":"insider","n_lines":2},{"id":7334767,"accession":"0001178913-10-001955","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001178913-10-001955","line_url":"/filing/0001178913-10-001955","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; SENATOR RON; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":7.2024,"price_display":"7.20","price_state":"stated","total_value":18006.0,"total_display":"18,006.00","total_whole":"18,006","shares_owned_after":225897.0,"shares_owned_after_display":"225,897","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-02-09","filed_date":"2010-07-29","scope":"insider","n_lines":2},{"id":7334763,"accession":"0001178913-10-001955","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001178913-10-001955","line_url":"/filing/0001178913-10-001955#line-16","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; SENATOR RON; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5521.0,"shares_display":"5,521","price_per_share":7.0631,"price_display":"7.06","price_state":"stated","total_value":38995.3751,"total_display":"38,995.38","total_whole":"38,995","shares_owned_after":653046.0,"shares_owned_after_display":"653,046","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-01-29","filed_date":"2010-07-29","scope":"insider"},{"id":7334762,"accession":"0001178913-10-001955","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001178913-10-001955","line_url":"/filing/0001178913-10-001955#line-15","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; SENATOR RON; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":7.0918,"price_display":"7.09","price_state":"stated","total_value":17729.5,"total_display":"17,729.50","total_whole":"17,730","shares_owned_after":647525.0,"shares_owned_after_display":"647,525","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-01-07","filed_date":"2010-07-29","scope":"insider"},{"id":7334760,"accession":"0001178913-10-001955","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001178913-10-001955","line_url":"/filing/0001178913-10-001955#line-14","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; SENATOR RON; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":7.6636,"price_display":"7.66","price_state":"stated","total_value":38318.0,"total_display":"38,318.00","total_whole":"38,318","shares_owned_after":645025.0,"shares_owned_after_display":"645,025","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-01-04","filed_date":"2010-07-29","scope":"insider"},{"id":7334757,"accession":"0001178913-10-001955","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001178913-10-001955","line_url":"/filing/0001178913-10-001955#line-13","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; SENATOR RON; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2400.0,"shares_display":"2,400","price_per_share":7.8063,"price_display":"7.81","price_state":"stated","total_value":18735.12,"total_display":"18,735.12","total_whole":"18,735","shares_owned_after":640025.0,"shares_owned_after_display":"640,025","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-31","filed_date":"2010-07-29","scope":"insider"},{"id":7334755,"accession":"0001178913-10-001955","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001178913-10-001955","line_url":"/filing/0001178913-10-001955#line-12","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; SENATOR RON; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":7.6043,"price_display":"7.60","price_state":"stated","total_value":19010.75,"total_display":"19,010.75","total_whole":"19,011","shares_owned_after":637625.0,"shares_owned_after_display":"637,625","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-30","filed_date":"2010-07-29","scope":"insider"},{"id":7334753,"accession":"0001178913-10-001955","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001178913-10-001955","line_url":"/filing/0001178913-10-001955#line-11","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; SENATOR RON; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3100.0,"shares_display":"3,100","price_per_share":7.3701,"price_display":"7.37","price_state":"stated","total_value":22847.31,"total_display":"22,847.31","total_whole":"22,847","shares_owned_after":635125.0,"shares_owned_after_display":"635,125","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-29","filed_date":"2010-07-29","scope":"insider"},{"id":7334751,"accession":"0001178913-10-001955","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001178913-10-001955","line_url":"/filing/0001178913-10-001955#line-10","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; SENATOR RON; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3600.0,"shares_display":"3,600","price_per_share":7.8161,"price_display":"7.82","price_state":"stated","total_value":28137.96,"total_display":"28,137.96","total_whole":"28,138","shares_owned_after":632025.0,"shares_owned_after_display":"632,025","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-14","filed_date":"2010-07-29","scope":"insider"},{"id":7334748,"accession":"0001178913-10-001955","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001178913-10-001955","line_url":"/filing/0001178913-10-001955#line-9","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; SENATOR RON; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5600.0,"shares_display":"5,600","price_per_share":7.7941,"price_display":"7.79","price_state":"stated","total_value":43646.96,"total_display":"43,646.96","total_whole":"43,647","shares_owned_after":628425.0,"shares_owned_after_display":"628,425","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-11","filed_date":"2010-07-29","scope":"insider"},{"id":7334745,"accession":"0001178913-10-001955","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001178913-10-001955","line_url":"/filing/0001178913-10-001955#line-8","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; SENATOR RON; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":7.7591,"price_display":"7.76","price_state":"stated","total_value":62072.8,"total_display":"62,072.80","total_whole":"62,073","shares_owned_after":622825.0,"shares_owned_after_display":"622,825","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-10","filed_date":"2010-07-29","scope":"insider"},{"id":7334743,"accession":"0001178913-10-001955","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001178913-10-001955","line_url":"/filing/0001178913-10-001955#line-7","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; SENATOR RON; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":7.4448,"price_display":"7.44","price_state":"stated","total_value":74448.0,"total_display":"74,448.00","total_whole":"74,448","shares_owned_after":614825.0,"shares_owned_after_display":"614,825","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-09","filed_date":"2010-07-29","scope":"insider"},{"id":7334740,"accession":"0001178913-10-001955","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001178913-10-001955","line_url":"/filing/0001178913-10-001955#line-6","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; SENATOR RON; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7600.0,"shares_display":"7,600","price_per_share":7.5478,"price_display":"7.55","price_state":"stated","total_value":57363.28,"total_display":"57,363.28","total_whole":"57,363","shares_owned_after":604825.0,"shares_owned_after_display":"604,825","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-08","filed_date":"2010-07-29","scope":"insider"},{"id":7334738,"accession":"0001178913-10-001955","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001178913-10-001955","line_url":"/filing/0001178913-10-001955#line-5","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":null,"owner_name":"SPHERA FUNDS MANAGEMENT LTD.; MOR ISRAEL; SENATOR RON; BREEN DORON","owner_display_name":"SPHERA FUNDS MANAGEMENT LTD.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":7.528,"price_display":"7.53","price_state":"stated","total_value":60224.0,"total_display":"60,224.00","total_whole":"60,224","shares_owned_after":597225.0,"shares_owned_after_display":"597,225","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-07","filed_date":"2010-07-29","scope":"insider"}],"collapsed":true,"next_cursor":"2009-12-07|7334738","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001785530","name":"Werewolf Therapeutics, Inc.","url":"/issuer/0001785530","role":"Ten percent owner","n_filings":1,"first_seen":"2021-05-04","last_seen":"2021-05-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001385830","name":"NeurogesX Inc","url":"/issuer/0001385830","role":"Other","n_filings":13,"first_seen":"2010-07-29","last_seen":"2011-08-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001382911","name":"Orexigen Therapeutics, Inc.","url":"/issuer/0001382911","role":"Other","n_filings":1,"first_seen":"2010-08-16","last_seen":"2010-08-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001496201","retrieved_at":"2026-08-22T06:59:33+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}